Archived Insight | April 10, 2020

Health Plan News and Strategies for Plan Sponsors: Q2 2020

This edition of Trends covers the COVID-19 crisis, cancer mortality rates, the role of biosimilars in lowering drug costs, and more. Download the latest issue now to stay ahead of the curve.

Download Now

Have questions? We have answers.

Get in touch today and let's help you solve whatever issues you're facing.

Learn more from Segal

Crowd Of People On The White House Grounds

How the One Big Beautiful Bill Act Will Impact Health Plans

Segal's July 30 webinar explores how the Big Beautiful Bill Act and recent SCOTUS rulings may reshape health plans and compliance strategies.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate

Q3 2025 Trends Focus: Specialty Dermatological Drugs

Learn about the rising cost of these drugs, emerging therapies for psoriasis, the biosimilar market and four cost-management strategies.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

Doctor Explaining The Diagnosis To A Girl And Her Father In The Consultation Room

Budget Act Provisions that Affect Employee Benefits

Plan sponsors: Review several parts of the bill, particularly those related to Health Savings Accounts (HSAs) and certain other fringe benefits.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate

Read Full Insight

Explore all COVID-19 information

We're regularly publishing information on the coronavirus as the situation changes.

Learn More

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.